An official website of the United States government
NIH Guide: Weekly Index for October 18, 2024
Weekly NIH Funding Opportunities and Notices
October 18, 2024
General Notices
-
Notice to Rescind NOT-AI-18-024 "Notice of NIAID's Interest in Continued Support of High Priority Immunology Grants"
(NOT-AI-24-083)National Institute of Allergy and Infectious Diseases
-
Notice of NIBIB Participation in RFA-NS-25-017: "BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed)"
(NOT-EB-24-016)National Institute of Biomedical Imaging and Bioengineering
-
Notice of NIBIB Participation in RFA-NS-25-018: "BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed)"
(NOT-EB-24-017)National Institute of Biomedical Imaging and Bioengineering
-
NIEHS Notice of Participation in PA-25-080 "Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not allowed)"
(NOT-ES-25-001)National Institute of Environmental Health Sciences
-
Notice Announcing Rescheduled Date for NICHD's Virtual Question and Answer "Informational Session" with NICHD Staff for the F99/K00 Predoctoral to Postdoctoral Transition Award
(NOT-HD-24-042)Eunice Kennedy Shriver National Institute of Child Health and Human Development
-
Notice of Pre-Application Webinar for C06 Research Facilities Construction Grants PAR-25-061 and PAR-24-033
(NOT-OD-25-011)Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
-
Notice to close RFA-OH-22-002 Centers for Agricultural Safety and Health (U54)
(NOT-OH-25-001)National Institute for Occupational Safety and Health
Notice of Changes to Funding Opportunities
-
Notice of Change to Key Dates for RFA-AG-25-007 and RFA-AG-25-008, Centers on the Demography and Economics of Aging, Including Alzheimer's Disease and Alzheimer's Disease-Related Dementias (D&E Centers) and D&E Coordinating Center
(NOT-AG-24-071)National Institute on Aging
-
Notice of NIAID Withdrawal of Participation from "Notice of Special Interest (NOSI): The Role of the Immune System in Aging Brain and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD)", NOT-AG-24-010
(NOT-AI-25-003)National Institute of Allergy and Infectious Diseases
-
Notice of Participation of NCCIH in NOT-ES-24-002, "Notice of Special Interest (NOSI): Innovative Technologies for Research on Climate Change and Human Health"
(NOT-AT-25-001)National Center for Complementary and Integrative Health
-
Notice of NIDA Participation in PA-25-080 "NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)"
(NOT-DA-24-050)National Institute on Drug Abuse
-
Notice of NICHD Key Date Changes for PA-23-189, "Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)"
(NOT-HD-24-038)Eunice Kennedy Shriver National Institute of Child Health and Human Development
-
Notice of Clarification of Instructions for the Scientific Administrative Core (SAC) and the Data Management and Analysis Core (DMAC) and Informational Webinar for RFA HD-25-003 " Pediatric HIV/AIDS Cohort Study (PHACS) (U19 Clinical Trial Not Allowed)
(NOT-HD-24-041)Eunice Kennedy Shriver National Institute of Child Health and Human Development
-
Notice of Participation of the National Institute of Nursing Research (NINR) in PA-25-080, "NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)"
(NOT-NR-25-002)National Institute of Nursing Research
-
Notice of Change: Update to Non-Responsive Criteria in PAR-23-311 and PAR-24-044
(NOT-NS-25-002)National Institute of Neurological Disorders and Stroke
Notices of Intent to Publish
-
Notice of Intent to Publish a Funding Opportunity Announcement for CCRP Initiative: Countermeasures Against Chemical Threats (CounterACT) Therapeutics Discovery and Early-Stage Development (UG3/UH3 Clinical Trial Not Allowed)
(NOT-NS-24-126)National Institute of Neurological Disorders and StrokeNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute on Drug AbuseNational Eye Institute
Funding Opportunities
-
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required)
(PAR-24-275)National Center for Complementary and Integrative HealthApplication Receipt Date(s): Multiple dates, see announcement.
-
Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required)
(PAR-24-276)National Center for Complementary and Integrative HealthApplication Receipt Date(s): Multiple dates, see announcement.
-
Emerging Global Leader Award (K43 Independent Clinical Trial Required)
(PAR-24-295)John E. Fogarty International CenterNational Institute on AgingNational Cancer InstituteNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Institute of Environmental Health SciencesNational Human Genome Research InstituteNational Heart, Lung, and Blood InstituteNational Institute of Mental HealthNational Institute of Neurological Disorders and StrokeOffice of Research on Women's HealthApplication Receipt Date(s): Multiple dates, see announcement.
-
Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
(PAR-24-296)John E. Fogarty International CenterNational Institute on AgingNational Cancer InstituteNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Institute of Dental and Craniofacial ResearchNational Institute of Environmental Health SciencesNational Eye InstituteNational Human Genome Research InstituteNational Heart, Lung, and Blood InstituteNational Institute of Mental HealthNational Institute of Neurological Disorders and StrokeOffice of Research on Women's HealthApplication Receipt Date(s): Multiple dates, see announcement.
-
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
(PAR-25-074)National Cancer InstituteApplication Receipt Date(s): Multiple dates, see announcement.
-
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
(PAR-25-075)National Cancer InstituteApplication Receipt Date(s): Multiple dates, see announcement.
-
NCI Small Grants Program for Cancer Research (NCI Omnibus) (R03 Clinical Trial Optional)
(PAR-25-078)National Cancer InstituteApplication Receipt Date(s): Multiple dates, see announcement.
-
Towards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses (R21 - Clinical Trial Optional)
(PAR-25-115)National Institute of Neurological Disorders and StrokeNational Institute of Mental HealthOffice of the Director, NIHApplication Receipt Date(s): Multiple dates, see announcement.
-
Towards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses (R01 - Clinical Trial Optional)
(PAR-25-116)National Institute of Neurological Disorders and StrokeNational Institute of Mental HealthOffice of the Director, NIHApplication Receipt Date(s): Multiple dates, see announcement.
-
NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)
(PAR-25-120)National Institute on Deafness and Other Communication DisordersApplication Receipt Date(s): Multiple dates, see announcement.
-
New Therapeutic Strategies for Genital Herpes (R21/R33 Clinical Trial Not Allowed)
(RFA-AI-24-068)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): January 31, 2025
-
Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial Optional)
(RFA-DA-25-070)National Institute on Drug AbuseApplication Receipt Date(s): Multiple dates, see announcement.
-
Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial required)
(RFA-DA-25-072)National Institute on Drug AbuseApplication Receipt Date(s): Multiple dates, see announcement.
-
TMD Collaborative for IMproving PAtient-Centered Translational Research (TMD IMPACT) (U54 Clinical Trial Optional)
(RFA-DE-25-003)National Institute of Dental and Craniofacial ResearchNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringOffice of Research on Women's HealthApplication Receipt Date(s): January 10, 2025
-
Building Biomedical Engineering Education, Research, and Innovation at Historically Black Colleges and Universities (HBCU eBETA) (UG3/UH3 Clinical Trial Not Allowed)
(RFA-EB-25-002)National Institute of Biomedical Imaging and BioengineeringApplication Receipt Date(s): September 30, 2025
NIH Funding Opportunities are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
This page last updated on: January 16, 2025
For technical issues E-mail OER Webmaster